Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 28, 2021
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc.
| 40K |
$4.20 | $168,000.00 | +6.16% | 689.08K | +1 |
Jul 26
| ||||||
Exelixis, Inc.
| 35K |
$4.20 | $147,000.00 | +5.70% | 649.08K | +1 |
Jul 21
| ||||||
Genocea Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Exelixis, Inc.
|
0
|
$13.64 | -$2,348,000.00 |
—
| 614.08K | +1 |
May 13
|
Scheduled
| |||||
Exelixis, Inc.
|
0
|
$13.35 | -$1,165,000.00 |
—
| 613.48K | +1 |
Apr 26
|
Scheduled
| |||||
Exelixis, Inc.
|
0
|
$12.35 | -$1,065,000.00 |
—
| 613.48K | +1 |
Apr 1
|
Scheduled
| |||||
Exelixis, Inc.
| 72.89K |
—
|
—
| +13.48% | 613.48K | +1 |
Mar 4
| ||||||
Exelixis, Inc.
|
0
|
$12.07 | -$2,072,500.00 |
—
| 540.6K | +1 |
Feb 17 - Feb 18
| ||||||
Exelixis, Inc.
| -2.86K |
$21.91 | -$62,618.78 | -0.53% | 540.6K | +1 |
Feb 15
| ||||||
Exelixis, Inc.
| 66.06K |
$22.56 | -$337,993.92 | +13.84% | 543.46K | +1 |
Feb 3
| ||||||
Exelixis, Inc.
| -14.95K |
$20.16 | -$301,452.48 | -3.04% | 477.4K | +1 |
Nov 15
| ||||||
Exelixis, Inc.
| 158.64K |
$21.79 | -$1,203,570.65 | +47.61% | 491.83K | +1 |
Oct 22
| ||||||
Exelixis, Inc.
| 7.23K |
$21.58 | -$54,316.86 | +2.22% | 333.19K | +1 |
Sep 2
| ||||||
Genocea Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Exelixis, Inc.
|
0
|
$12.33 | -$2,126,000.00 |
—
| 325.96K | +1 |
Jun 4
|
Scheduled
| |||||
Exelixis, Inc.
|
0
|
$13.85 | -$2,430,000.00 |
—
| 325.12K | +1 |
Apr 23
|
Scheduled
| |||||
Exelixis, Inc.
|
0
|
$10.55 | -$1,770,000.00 |
—
| 325.12K | +1 |
Mar 4
| ||||||
Exelixis, Inc.
|
0
|
$13.51 | -$639,600.00 |
—
| 325.12K | +1 |
Feb 19
|
Scheduled
| |||||
Genocea Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 14
| |||||||
Genocea Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Exelixis, Inc.
|
0
|
$11.94 | -$643,000.00 |
—
| 325.12K | +1 |
Feb 7
|
Scheduled
| |||||
Exelixis, Inc.
|
0
|
$11.74 | -$622,500.00 |
—
| 325.12K | +1 |
Jan 7
|
Scheduled
| |||||
Exelixis, Inc.
| 11.56K |
$17.67 | -$71,157.09 | +3.69% | 325.12K | +1 |
Dec 4
| ||||||
Exelixis, Inc.
|
0
|
$10.86 | -$535,500.00 |
—
| 313.56K | +1 |
Dec 3
|
Scheduled
| |||||
Exelixis, Inc.
| -12.27K |
$16.51 | -$202,544.68 | -3.77% | 313.56K | +1 |
Nov 15
| ||||||
Exelixis, Inc.
|
0
|
$10.75 | -$524,000.00 |
—
| 324.33K | +1 |
Nov 4
|
Scheduled
| |||||
Exelixis, Inc.
|
0
|
$11.69 | -$370,800.00 |
—
| 324.33K | +1 |
Oct 1
|
Scheduled
| |||||
Exelixis, Inc.
| 7.82K |
$19.26 | -$49,633.02 | +2.47% | 324.33K | +1 |
Sep 12
| ||||||
Exelixis, Inc.
|
0
|
$16.09 | -$1,124,602.38 |
—
| 316.51K | +1 |
Apr 3
|
Scheduled
| |||||
Exelixis, Inc.
|
0
|
$15.16 | -$1,596,000.00 |
—
| 316.51K | +1 |
Mar 25
|
Scheduled
| |||||
Exelixis, Inc.
|
0
|
$13.66 | -$1,992,720.00 |
—
| 316.51K | +1 |
Feb 14 - Feb 15
| ||||||
Exelixis, Inc.
|
0
|
$13.03 | -$215,714.02 |
—
| 316.51K | +1 |
Dec 3
|
Scheduled
| |||||
Exelixis, Inc.
| -11.78K |
$17.45 | -$205,473.75 | -3.59% | 316.51K | +1 |
Nov 15
| ||||||
Exelixis, Inc.
|
0
|
$9.60 | -$109,440.00 |
—
| 328.29K | +1 |
Nov 1
|
Scheduled
| |||||
Exelixis, Inc.
|
0
|
$11.41 | -$152,760.00 |
—
| 328.29K | +1 |
Oct 1
|
Scheduled
| |||||
Exelixis, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Sep 10
| ||||||
Exelixis, Inc.
|
0
|
$12.02 | -$293,175.00 |
—
| 328.29K |
Sep 4
|
Scheduled
| ||||||
Exelixis, Inc.
| 50K |
$5.51 | $275,500.00 | +17.97% | 328.29K |
Aug 17
| |||||||
Exelixis, Inc.
|
0
|
$13.03 | -$338,850.00 |
—
| 278.29K |
Aug 1
|
Scheduled
| ||||||
Exelixis, Inc.
|
0
|
$13.35 | -$353,250.00 |
—
| 278.29K |
Jul 2
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.